Therapeutic effect of traditional Chinese medicine on coagulation disorder and accompanying intractable jaundice in hepatitis B virus-related liver cirrhosis patients

Table 3 Balance test for indexes of liver function before treatment (mean ± SD)

		ALT (U/L)	AST (U/L)	TBIL (μmol/L)	ALB (g/L)
Fib (1.6-2.0 g/L) level	Research group	180.90 ± 255.59	163.17 ± 176.13	104.51 ± 65.26	32.79 ± 4.69
	Control group	241.87 ± 349.01	190.87 ± 191.11	126.97 ± 61.69	33.47 ± 3.72
	P value	0.089	0.562	0.176	0.537
Fib (1.1-1.5 g/L) level	Research group	118.57 ± 121.99	144.37 ± 113.62	129.71 ± 95.70	31.74 ± 4.69
	Control group	234.07 ± 392.07	232.87 ± 265.04	169.95 ± 156.22	29.59 ± 5.54
	P value	0.129	0.098	0.234	0.111
Fib ( ≤ 1.0 g/L) level	Research group	74.40 ± 30.89	92.40 ± 78.44	198.40 ± 123.37	29.60 ± 3.82
	Control group	181.67 ± 283.59	142.80 ± 128.34	245.57 ± 193.69	30.15 ± 6.61
	P value	0.249	0.280	0.503	0.817

Anyone in the three subgroups divided by the standard of Fib level and the indexes of liver function was balanced between research and control groups before treatment.